<DOC>
	<DOCNO>NCT01080768</DOCNO>
	<brief_summary>The purpose present study evaluate addition aliskiren , amlodipine attenuate ankle edema formation hypertensive patient .</brief_summary>
	<brief_title>Assessment Aliskiren/Amlodipine Amlodipine Ankle Foot Volume ( AFV ) Patients With Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<criteria>Patients ( male female ) hypertension age 1875 yr . Patients treat amlodipine amlodipine previous 1 year . Postmenopausal females Patients unable switch prior hypertensive medication . Severe hypertension . Pregnant nursing female . Patients Type 1 Type 2 diabetes mellitus History immunodeficiency disease , include positive Human immunodeficiency virus ( HIV ) ( Enzymelinked immunosorbent assay [ ELISA ] Western blot ) test result . A positive Hepatitis B surface antigen ( HBsAg ) Hepatitis C test result . Other protocoldefined inclusion/exclusion criterion apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2011</verification_date>
	<keyword>Pedal edema</keyword>
	<keyword>hypertension</keyword>
	<keyword>aliskiren</keyword>
	<keyword>amlodipine</keyword>
</DOC>